Company Profile
Updated: 30-OCT-09Pierre Fabre Medicament Production S.A.S.
International Private company
45 Pl. Abel Glance, Boulagne Billancourt, F-92100, France
()33 01 49 10 80 00, 33 01 49 10 96 23 fax, http://www.pierre-fabre.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture of pharmaceutical preparations for the following therapeutic areas: cancerology, urology, cardiology, psychiatry, phlebology, pneumology, infectiology, gynaecology and rhumatology
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/3/2009; 3308 words; ...of San Diego, said that Pierre Fabre Medicament SA, a division of Paris-based bioMerieux Pierre Fabre, milnacipran's originator, plans to set up a second milnacipran production site in Castres, France...
Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma.
PR Newswire Europe; 5/6/2009; 970 words; ...development, production and marketing...Alain Taieb's department...agreement with Pierre Fabre Dermatologie...Pierre Fabre Laboratories, France's second biggest...Furterer. Pierre Fabre Dermatologie...Pierre Fabre Medicament dedicated...
OTCPicks.com Stocks to Watch for Wednesday, November 19th ESNR, SEWC, IDMI, TRXX.
M2 Presswire; 11/19/2008; 3387 words; ...popular television productions as CSI Miami...The Company's 20+ year history...to the company's list of achievements...The company's products include...Institut de Recherche Pierre Fabre and Pierre Fabre Medicament S.A. The company...
THE EUROPEAN OUTSOURCING AWARDS 2008
Pharma; 11/1/2008; 4694 words; ...reports on the evening's revelations. According...results of this year's European Outsourcing Awards...ceremony at Frankurt's Steigenberger Frankfurter...on stage this year was Pierre Fabre Medicament Productions for the nomination...
WIPO: Inventors in France Develop Novel Quinuclidine Derivative
US Fed News Service, Including US State News; 10/3/2008; 409 words; ...synthesis intermediate for the production of mequitazine." The...patent has been assigned to Pierre Fabre Medicament, Boulogne-Billancourt...786-9199 (in the U.S. or Canada) or 703...assistance from a U.S. Patent & Trademark...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning